Sign in

You're signed outSign in or to get full access.

Deep Nishar

Director at Seer
Board

About Deep Nishar

Dipchand (Deep) Nishar, age 56 as of March 31, 2025, has served as an independent director of Seer, Inc. since February 2021. He is a Managing Director at General Catalyst (since January 2022) and previously was Senior Managing Partner at SoftBank Investment Advisers (2015–2021). Earlier roles include product leadership at LinkedIn (SVP Product & UX) and Google (Senior Director of Products, APAC). He holds a B.Tech (IIT), M.S. in Electrical Engineering (University of Illinois Urbana-Champaign), and an MBA (Harvard Business School) .

Past Roles

OrganizationRoleTenureCommittees/Impact
SoftBank Investment Advisers (US) Inc.Senior Managing PartnerJun 2015–Dec 2021
LinkedIn CorporationVP Products; SVP Product & User ExperienceJan 2009–Oct 2014
Google Inc.Senior Director of Products, APAC (and other roles)Aug 2003–Jan 2009

External Roles

OrganizationRoleTenureCommittees/Notes
General CatalystManaging DirectorJan 2022–PresentInvestment activities in life sciences
Dynamics Special Purpose Corp.DirectorMay 2021–Jun 2022Public company board (SPAC)
Vir Biotechnology, Inc.DirectorAug 2017–Jun 2022Public company board
Guardant Health, Inc.DirectorOct 2018–Jun 2020Public company board
Relay Therapeutics, Inc.DirectorJun 2019–Dec 2021Public company board
TripAdvisor, Inc.DirectorAug 2013–Jun 2019Public company board
Zymergen Inc.DirectorOct 2016–Sep 2020Public company board
Several privately-held companiesDirectorCurrentNot specified

Board Governance

  • Independence: The board determined Mr. Nishar is independent under Nasdaq standards; 5 of 7 directors are independent .
  • Committee assignments (2025 proxy): Member, Corporate Governance & Nominating Committee (Chair: Nicolas Roelofs, Ph.D.); Member, Science & Technology Committee (Chair: Robert Langer, Sc.D.) .
  • Attendance: In 2024, the board met 5 times; each director attended at least 75% of board and applicable committee meetings .
  • Committee activity 2024: T&C Committee (5 meetings), Corporate Governance & Nominating (3 meetings), Science & Technology (1 meeting) .
  • Board leadership: CEO serves as Chair; Lead Independent Director role held by Nicolas Roelofs since Aug 13, 2024 .

Fixed Compensation

  • 2024 director fees paid to Deep Nishar: | Year | Fees Earned or Paid in Cash ($) | |---|---| | 2024 | 52,500 |

  • Outside Director Fee Schedule (policy amounts applicable in 2024/2025):

    • Annual retainer: $42,500 (increased from $40,000 on Feb 28, 2024)
    • Committee membership fees: CG&N member $5,000; Science & Technology member $5,000; Chair fees higher (CG&N Chair $10,000; S&T Chair $10,000)
    • Lead Independent Director: $25,000
    • Audit Committee member $10,000; Chair $20,000; T&C member $7,500; Chair $15,000

Note: Mr. Nishar’s $52,500 cash aligns with the policy math for 2024: $42,500 retainer + $5,000 (CG&N member) + $5,000 (S&T member) .

Performance Compensation

  • 2024 equity to Deep Nishar: | Year | Stock Awards ($) | Option Awards ($) | |---|---|---| | 2024 | 108,793 | — |

  • Director Equity Program Details (policy mechanics and vesting): | Program Element | 2024 Policy | 2025 Policy (as amended Feb 26, 2025) | Vesting and Other Terms | |---|---|---|---| | Initial Award on joining board | Options for 69,470 shares + RSUs for 46,886 shares | Options for 61,000 shares + RSUs for 41,000 shares | Vests in 3 equal annual installments from start date, subject to service | | Annual Award at each AGM | RSUs for 58,178 shares | Options for 30,500 shares + RSUs for 20,500 shares | Vests in full on earlier of 1-year anniversary or day before next AGM; prorated if partial year of service | | Change in Control | — | Outstanding director equity vests fully if serving through change in control |

Other Directorships & Interlocks

  • Current public company boards: None disclosed; currently serves on several privately-held company boards .
  • Prior public company boards: Dynamics Special Purpose Corp. (2021–2022), Vir Biotechnology (2017–2022), Guardant Health (2018–2020), Relay Therapeutics (2019–2021), TripAdvisor (2013–2019), Zymergen (2016–2020) .
  • Compensation committee interlocks: None reported for Seer’s T&C Committee in 2024; committee members were independent and no executive officer served on another company’s comp committee that had an executive serving on Seer’s board .

Expertise & Qualifications

  • Technology and product leadership (Google, LinkedIn) and life sciences investing (SoftBank IA; General Catalyst) .
  • Education: B.Tech (IIT), M.S. EE (UIUC), MBA (Harvard Business School) .
  • Board-relevant skills cited by Seer: extensive technology background and investment activities in life sciences sector .

Equity Ownership

HolderClass A Shares Beneficially Owned% of Class A OutstandingClass B SharesNotes
Dipchand (Deep) Nishar94,375<1%As of Mar 31, 2025; ownership per SEC rules
  • Context: Total outstanding as of Mar 31, 2025 was 55,385,066 Class A and 4,044,969 Class B; Class B converts 1:1 into Class A and automatically converts on Dec 9, 2025 .

Governance Assessment

  • Strengths:

    • Independent director with relevant tech and life science investing background; serves on governance and science/technology committees, aligning expertise with oversight needs .
    • Attendance at least 75% of board/committee meetings in 2024, meeting typical governance thresholds .
    • Director pay structure is equity-heavy (2024: $108,793 stock awards vs $52,500 cash), aligning interests with shareholders; policy updated in 2025 to include options plus RSUs, potentially increasing performance linkage for directors .
    • No related-party transactions involving Mr. Nishar disclosed since January 1, 2023 .
  • Watch items:

    • SoftBank SB Global Advisers Limited is a >5% stockholder; Mr. Nishar previously held a senior role at SoftBank Investment Advisers (ended 2021). The board has determined independence, and no related-party transactions are disclosed, but investors may monitor for potential perceived alignment issues given SoftBank’s stake .
    • Seer does not disclose director stock ownership guidelines; the company notes no ownership guidelines for named executive officers (directors not specified), which some investors view as an alignment gap .
  • RED FLAGS: None disclosed specific to Mr. Nishar (no low attendance, no related-party transactions, no director-specific pay anomalies reported) .